15
Participants
Start Date
March 31, 2009
Primary Completion Date
August 31, 2012
Study Completion Date
November 30, 2012
Lenalidomide, Decitabine
Decitabine 20mg/m2 over one hour IV for 5 days, with cycles repeated every 28 days. Lenalidomide given orally on Days 1-21 followed by 7 days of rest at various dose escalated cohorts (5 mg, 10mg, 15mg, 20 mg, 25 mg)
Duke University Medical Center, Durham
Lead Sponsor
Collaborators (1)
Celgene Corporation
INDUSTRY
Duke University
OTHER